top of page

Veradermics, a company trying to change hair loss, so far has been one of the best performing IPOs in biotech in many years

1 day ago
1 min read

CEO Reid Waldman walks us through the company's treatment, VDPHL01, which is an extended-release oral formulation of minoxidil, and he sets the table for three key readouts the company has coming up. Plus, the company's regulatory strategy and how he sees the commercial market.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

10x_Genomics_logo.svg.png

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.

 

Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

bottom of page